Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 12) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) BIO-TECHNE Corp (NASDAQ: TECH ) EXACT Sciences Corporation (NASDAQ: EXAS ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 12) Acorda Therapeutics Inc (NASDAQ: ACOR ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) BRAINSWAY LTD/S ADR (NASDAQ: BWAY ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Minerva Neurosciences Inc (NASDAQ: NERV ) Navidea Biopharmaceuticals Inc (NYSE: NAVB ) NextCure Inc (NASDAQ: NXTC ) Novavax, Inc. (NASDAQ: NVAX ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obseva SA (NASDAQ: OBSV ) RA Medical Systems Inc (NYSE: RMED ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Sensus Healthcare Inc (NASDAQ: SRTS ) Sierra Oncology Inc (NASDAQ: SRRA ) Unum Therapeutics Inc (NASDAQ: UMRX ) Zomedica Pharmaceuticals Corp (NYSE: ZOM ) Stock In Focus Savara's Pulmonary Disease Drug Does Not Meet Primary Endpoint In Late-stage Study Savara Inc (NASDAQ: SVRA ) said a Phase 3 study dubbed IMPALA that evaluated its …

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 10) Abbott Laboratories (NYSE: ABT ) BIO-TECHNE Corp (NASDAQ: TECH ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Stellar Biotechnologies Inc (NASDAQ: EDSA ) EXACT Sciences Corporation (NASDAQ: EXAS ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Kodiak Sciences Inc (NASDAQ: KOD ) Provention Bio Inc (NASDAQ: PRVB )( announced positive results for its PRV-031 in at-risk Type 1 diabetes patient) Down In The Dumps (Biotech stocks hitting 52-week lows on June 10) Abeona Therapeutics Inc (NASDAQ: ABEO ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Endo International PLC (NASDAQ: ENDP ) Insys Therapeutics Inc (NASDAQ: INSY )( filed for bankruptcy protection) Novavax, Inc (NASDAQ: NVAX )(reacted to the news of FDA requiring an additional Phase 3 study for its respiratory syncytial virus vaccine ResVax) Sensus Healthcare Inc (NASDAQ: SRTS ) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) T2 Biosystems Inc (NASDAQ: TTOO ) Teligent Inc (NASDAQ: TLGT ) Stock In Focus Eli Lily Presents Positive Long-term Efficacy Data For Psoriasis Treatment Eli Lilly And Co (NYSE: LLY ) said it will present at the World Congress of Dermatology positive five-year Phase 3 data for Taltz in patients with moderate-to-severe plaque psoriasis.

Read more

Sensus Healthcare's (NASDAQ:SRTS) Q1 2019 Earnings Conference Call May 09, 2019 05:00 PM ET Company Participants Arthur Levine - CFO Joseph Sardano - Chairman,

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 8) Alcon AG (NYSE: ALC ) BioSig Technologies Inc (NASDAQ: BSGM ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 8) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Aquestive Therapeutics Inc (NASDAQ: AQST )(reacted to first-quarter results) Arbutus Biopharma Corp (NASDAQ: ABUS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Flexion Therapeutics Inc (NASDAQ: FLXN ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Opko Health Inc. (NASDAQ: OPK )(reacted to Q1 results) Osmotica Pharmaceuticals PLC (NASDAQ: OSMT ) Retrophin Inc (NASDAQ: RTRX ) Revance Therapeutics Inc (NASDAQ: RVNC ) Sensus Healthcare Inc (NASDAQ: SRTS ) Stock In Focus Novartis to Buy Dry Eye Disease Drug From Takeda For $3.4B Novartis AG (NYSE: NVS ) announced an agreement with Takeda Pharmaceutical Co Ltd (NYSE: TAK ) to acquire the assets associated with Xildra, chemically lifitefgrast ophthalmic solution, 5 percent worldwide for a $3.4 billion payment upfront and potential milestone payments up to $1.9 billion.

Read more

The Prognosis For Sensus Healthcare
10:50pm, Monday, 29'th Apr 2019

Read more

Apyx Medical Corporation (NASDAQ:APYX) and Sensus Healthcare Inc. (NASDAQ:SRTS), are influenced by compare since they are both players in the Medical Instruments & Supplies. These factors are particul

Read more

Since Sensus Healthcare Inc. (NASDAQ:SRTS) and InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) are part of the Medical Instruments & Supplies industry, they are influenced by contrast. The influences par

Read more

AngioDynamics Inc. (NASDAQ:ANGO) and Sensus Healthcare Inc. (NASDAQ:SRTS), both competing one another are Medical Instruments & Supplies companies. We will compare their profitability, analyst recomme

Read more

Sensus Healthcare Inc. (NASDAQ:SRTS) and AtriCure Inc. (NASDAQ:ATRC) compete against each other in the Medical Instruments & Supplies sector. We will compare them and contrast their analyst recommenda

Read more

On May, 2. Investors expect Sensus Healthcare, Inc. (NASDAQ:SRTS) to report its quarterly earnings, Faxor reports. The EPS diference is $0.05 or 62.50 % up

Read more

Penumbra Inc. (NYSE:PEN) and Sensus Healthcare Inc. (NASDAQ:SRTS) are two firms in the Medical Instruments & Supplies that compete against each other. Below is a comparison of their risk, analyst reco

Read more

Presbia PLC (NASDAQ:LENS) and Sensus Healthcare Inc. (NASDAQ:SRTS) have been rivals in the Medical Instruments & Supplies for quite some time. Below is a review of each business including various aspe

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank